Michael Tardugno

Michael Tardugno

Chairman at IMUNON, INC.

Net worth: 38 063 $ as of 30/05/2026

75 year
Health Technology
Process Industries
Consumer Services

Profile

Mr. Michael H.
Tardugno
is an Executive Chairman at Imunon, Inc. Mr. Tardugno was previously employed as a Senior Vice President & General Manager by Mylan Technologies, Inc., an Executive Vice President by Songbird Holdings LLC, a Senior Vice President-Technical Operations by Bristol Myers Squibb Co., a Senior Vice President-Technical Operations by Convatec, Inc., a Plant Manager-Ross Laboratories Division by Abbott Laboratories, and a VP-Technology Development & Manufacturing by Bausch & Lomb, Inc. He also served on the board at THO Inc.,.
He received his undergraduate degree from St. Bonaventure University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 17,460 ( 0.69% ) 38 063 $ 30/05/2026

Michael Tardugno active positions

CompaniesPositionStart
IMUNON, INC. Chairman 06/10/2014

Former positions of Michael Tardugno

CompaniesPositionEnd
Chief Operating Officer 30/11/2006
Corporate Officer/Principal 31/12/2004
Chief Tech/Sci/R&D Officer 31/12/1997
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 31/12/1997
Corporate Officer/Principal 31/12/1994
See the detail of Michael Tardugno's experience

Training of Michael Tardugno

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

75

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Tardugno
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!